Oral squamous cell carcinoma - Contribution of oncogenic virus and some molecular markers in the development and prognosis of the lesion: A review;Carcinoma de células escamosas oral - Contribuição de vírus oncogênicos e alguns marcadores moleculares no desenvolvimento e prognóstico da lesão: Uma revisão

Revista Brasileira de Otorrinolaringologia

Volumn 70, Issue 3, 2004, Pages 385-392

  Venturi, Beatriz Da Rocha Miranda ^a,b,f   Cabral, Márcia Grillo ^b,c   Lourenço, Simone De Queiroz Chaves ^d,e  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^e FOUSP Bauru   (Brazil)

^f FOUSP Bauru ^*  (Brazil)

Author keywords

Oncogenic virus; Oral carcinoma; Telomerase

Indexed keywords

ALCOHOL; MOLECULAR MARKER; PROTEIN P53; TELOMERASE;

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CARCINOGENESIS; EPSTEIN BARR VIRUS; MOUTH CARCINOMA; ONCOGENE; ONCOVIRINAE; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WART VIRUS;

EID: 12344329574     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992004000300015     Document Type: Review

References (30)

1. a ed. Rio de Janeiro: Guanabara-Koogan; 1998. 705p.
2. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. JNCI 2000; 92(9): 709-20.
3. Llewellyn CD, Johnson NW, Warnakulasuriya KAAS. Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol 2001; 37(5): 401-18.
4. Llewellyn CD, Linklater K, Bell J et al. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the south east of England from 1990 to 1997. Oral Oncol 2003; 39: 106-14.
5. Atula S, Grenman R, Laippala P, Syrjanen S. Cancer of tongue in patients younger than 40 years: a distinct entity? Arch Otolaryngol Head Neck Surg 1996; 122(2): 1313-9.
6. Veldman T, Horikawa I, Barrett JC, Schlegel R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol 2001; 75(9):4467-72.
7. Fujimoto R, Kamata N, Yokoyama K et al. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol 2001; 37: 132-40.
8. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol 2002; 38: 227-34.
9. Belair CD, Yeager TR, Lopea PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997; 94: 13677-82.
10. Lydiatt D. Cancer of the oral cavity and medical malpractice. Laryngoscope 2002; 112(5): 816-9.
11. Oliver RJ, Dearing J, Hindle I. Oral cancer in young adults: report of three cases and review of the literature. Br Dent J 2000; 188(7): 362-6.
12. Miller CS, Johnstone, BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91(6): 622-35.
13. Lype EM, Pandey M, Mathew A et al. Oral cancer among patients under the age of 35 years. J Postgrad Med 2001; 47(3): 171-6.
14. Wattre P. Apoptose et virus (hormis les retrovirus). Revue Franγaise des Laboratoires 1999; 311: 43-9.
15. Bouda M, Gorgoulis VG, Kastrinakis NG et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-53.
16. Cruz IBF, Snijders PJF, Steenbergen RDM et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Oral Oncol 1996; 32B (1): 55-62.
17. Mork J, Lie AK, Glattre E et al. Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Engl J Med 2001; 344(15): 1125-31.
18. Premoli-De-Percoco G, Ramirez JL, Galindo I. Correlation between HPV types associated with oral squamous cell carcinoma and cervicovaginal cytology: an in situ hybridization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86(1): 77-81.
19. Capone RB, Pai SI, Koch WM et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV - associated head and neck squamous cell carcinoma. Clin Cancer Res 2000; 6(11): 4171-5.
20. Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol 2003; 39: 222-31.
21. Sand LP, Jalouli J, Larson P-A, Hirsch J-M. Prevalence of Eptein-Barr virus in oral squamous cell carcinoma, oral lichen planus, and normal oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93(5): 586-92.
22. Cruz I, Van Den Brule AJ, Brink AA et al. No direct role for Epstein-Barr virus in oral carcinogenesis: a study at the DNA, RNA and protein levels. Int J Cancer 2000; 86: 356-61.
23. Maeda T, Hiranuma H, Matsumura S, Furukawa S, Fuchihata H. Epstein-Barr virus infection and response to radiotherapy in squamous cell carcinoma of the oral cavity. Cancer Letters 1998; 125: 25-30.
24. Gonzalez-Moles MA, Gutierrez J, Rodriguez MJ, Ruiz-Avila I, Rodriguez-Archilla A. Epstein-Barr virus latent membrane protein - 1 (LMP-1) expression in oral squamous cell carcinoma. Laryngoscope 2002; 112(3): 482-7.
25. Fields BN, Knipe DM, Howley PM. Fields Virology. Philadelphia: Lippincott-Raven Publishers; 1996.
26. Hsieh LL, Wang P-F, Chen IW et al. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarrete smoking in Taiwanese. Carcinogenesis 2001; 22(9): 1497-503.
27. Gonzalez-Moles MA, Galindo P, Gutierrez J et al. Expression of the p53 protein in oral squamous cell carcinomas associated with Epstein-Barr virus. Microbios 2000; 102(403): 147-54.
28. Optiz OG, Suliman Y, Hahn WC et al. Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest. 2001; 108(5): 725-32.
29. Liao J, Mitsuyasu T, Yamane K, Ohishi M. Telomerase activity in oral and maxillofacial tumors. Oral Oncol 2000; 36: 347-52.
30. Schliephake H. Prognostic relevance of molecular markers of oral cancer - a review. Int J Oral Maxillofac Surg 2003; 32: 233-45.